Cargando…
Innovative intraoral cooling device better tolerated and equally effective as ice cooling
PURPOSE: Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake...
Autores principales: | Walladbegi, Java, Gellerstedt, Martin, Svanberg, Anncarin, Jontell, Mats |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676821/ https://www.ncbi.nlm.nih.gov/pubmed/28975429 http://dx.doi.org/10.1007/s00280-017-3434-2 |
Ejemplares similares
-
Protocol for a randomised controlled trial to study cryoprevention of chemotherapy-induced oral mucositis after autologous stem cell transplantation
por: Walladbegi, Java, et al.
Publicado: (2018) -
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial
por: Walladbegi, Java, et al.
Publicado: (2021) -
An extraoral approach to intraoral cooling–a feasibility study in non-cancer patients
por: Najaf, L., et al.
Publicado: (2023) -
Hemodynamics of the oral mucosa during cooling: A crossover clinical trial
por: Walladbegi, J., et al.
Publicado: (2023) -
Cooling in ICE
por: Bell, M
Publicado: (1979)